Unai Aranda

机构：AstraZeneca (Spain), AstraZeneca (United States)

发表论文 23 篇 · 总被引 178 次 · h-index 8

代表论文

Costs and healthcare utilisation of patients with chronic kidney disease in Spain (2021 · BMC Health Services Research · 被引 36)
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain (2021 · Nefrología (English Edition) · 被引 29)
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain (2021 · Nefrología · 被引 21)
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease (2022 · Clinical Kidney Journal · 被引 20)
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review (2025 · Advances in Therapy · 被引 13)
Proyección de la carga clínica y económica de la enfermedad renal crónica entre 2022 y 2027 en España: resultados del proyecto Inside CKD (2024 · Nefrología · 被引 11)